2016
DOI: 10.1080/15384101.2016.1252885
|View full text |Cite
|
Sign up to set email alerts
|

Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic model

Abstract: Rhabdomyosarcoma (RMS) is a rare mesenchymal tumor. The aim of the present study was to develop a patientderived orthotopic xenograft (PDOX) mouse model of RMS and compare the PDOX model to a subcutaneous (s.c.)-transplant model. A patient RMS from a striated muscle was grown orthotopically in the right biceps femoris muscle and right quadriceps muscle of nude mice to establish a PDOX model, as well as under the skin to establish an s.c. model. PDOX tumors grew at a statistically-significant faster rate compar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
54
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
8

Relationship

5
3

Authors

Journals

citations
Cited by 47 publications
(55 citation statements)
references
References 27 publications
(24 reference statements)
0
54
0
Order By: Relevance
“…PDOX models thus far developed are pancreatic [Fu et al, ; Hiroshima et al, ,, ], breast [Fu et al, ], ovarian [Fu and Hoffman, ], lung [Wang et al, ], cervical [Hiroshima et al, ; Murakami et al, ], colon [Fu et al, ; Metildi et al, ; Hiroshima et al, ], and stomach cancers [Furukawa et al, ], sarcoma [Hiroshima et al, ,; Kiyuna et al, ; Murakami et al, ,], and melanoma [Yamamoto et al, ; Kawaguchi et al, ,]. PDOX models of sarcoma that we have developed include undifferentiated pleomorphic sarcoma (UPS) [Murakami et al, ; Kiyuna et al, ], follicular dendritic cell sarcoma (FDCS) [Kiyuna et al, ], rhabdomyosarcoma (RMS) [Igarashi et al, ], Ewing's sarcoma [Murakami et al, ], and osteosaroma [Murakami et al, ]. The present manuscript describes a PDOX model of undifferentiated spindle‐cell sarcoma (USCS).…”
mentioning
confidence: 99%
“…PDOX models thus far developed are pancreatic [Fu et al, ; Hiroshima et al, ,, ], breast [Fu et al, ], ovarian [Fu and Hoffman, ], lung [Wang et al, ], cervical [Hiroshima et al, ; Murakami et al, ], colon [Fu et al, ; Metildi et al, ; Hiroshima et al, ], and stomach cancers [Furukawa et al, ], sarcoma [Hiroshima et al, ,; Kiyuna et al, ; Murakami et al, ,], and melanoma [Yamamoto et al, ; Kawaguchi et al, ,]. PDOX models of sarcoma that we have developed include undifferentiated pleomorphic sarcoma (UPS) [Murakami et al, ; Kiyuna et al, ], follicular dendritic cell sarcoma (FDCS) [Kiyuna et al, ], rhabdomyosarcoma (RMS) [Igarashi et al, ], Ewing's sarcoma [Murakami et al, ], and osteosaroma [Murakami et al, ]. The present manuscript describes a PDOX model of undifferentiated spindle‐cell sarcoma (USCS).…”
mentioning
confidence: 99%
“…Tumors were prepared for histological analysis using including hematoxylin and eosin (H&E) staining using previously published protocols (26).…”
mentioning
confidence: 99%
“…Recently, PDOX models of sarcoma (47)(48)(49)(50)(51)(52)(53)(54)(55)(56)(57)(58)(59)(60)(61)(62)(63)(64), cervical cancer (65-67) as well as melanoma (68)(69)(70)(71)(72)(73)(74) have also been developed.…”
Section: Patient-derived Orthotopic Xenograft (Pdox) Mouse Models Of mentioning
confidence: 99%